Related Experiment Videos

[Cryosurgery: an effective alternative treatment modality for large lentigo maligna]

N Cordel¹, M-C Boullie, P Joly

¹Clinique Dermatologique, CHU Charles Nicolle, 1 rue de Germont, 76031 Rouen Cedex, France.

Annales De Dermatologie Et De Venereologie

|July 6, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.

The British journal of dermatology·2021

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

The British journal of dermatology·2021

Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.

The British journal of dermatology·2021

See all related articles